Invenomic Capital Management’s Koppers KOP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-34,118
Closed -$1.1M 160
2025
Q2
$1.1M Sell
34,118
-6,710
-16% -$193K 0.06% 140
2025
Q1
$1.14M Buy
+40,828
New +$1.23M 0.06% 162
2023
Q1
Sell
-281,505
Closed -$7.94M 162
2022
Q4
$7.94M Sell
281,505
-15,021
-5% -$405K 0.54% 64
2022
Q3
$6.16M Buy
296,526
+59,061
+25% +$1.36M 0.53% 63
2022
Q2
$5.38M Buy
237,465
+1,333
+0.6% +$33.8K 0.38% 77
2022
Q1
$5.21M Buy
236,132
+48,397
+26% +$1.43M 0.56% 56
2021
Q4
$5.88M Sell
187,735
-73,567
-28% -$2.4M 1.26% 23
2021
Q3
$8.17M Buy
261,302
+71,438
+38% +$2.22M 2.65% 6
2021
Q2
$6.14M Buy
189,864
+90,773
+92% +$3.06M 1.47% 9
2021
Q1
$3.44M Buy
99,091
+12,953
+15% +$454K 0.77% 25
2020
Q4
$2.68M Buy
+86,138
New +$2.24M 0.68% 26

Other funds holding KOP

Invenomic Capital Management's KOP Position: Q3 2025 in Review

Invenomic Capital Management sold out of Koppers (KOP) in Q3 2025, closing a stake of 34,118 shares — an estimated $1.1M sold.

Invenomic Capital Management first reported a position in KOP in Q4 2020 and held it in 11 quarters. The position peaked at $8.17M in Q3 2021. 200 funds tracked by Wall St. Rank hold KOP as of Q3 2025.

  • Invenomic Capital Management reported no remaining Koppers position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 34,118 Koppers shares in Q3 2025, an estimated $1.1M.
  • Invenomic Capital Management first reported a position in Koppers in Q4 2020 and held it in 11 quarters.
  • Invenomic Capital Management's Koppers position peaked at $8.17M in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Koppers as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.